In vitro toxicity of naphthalene, 1-naphthol, 2-naphthol and 1,4-naphthoquinone on human CFU-GM from female and male cord blood donors

Toxicology in Vitro

Volumn 22, Issue 6, 2008, Pages 1555-1561

  Croera, C ^a   Ferrario, D ^a   Gribaldo, L ^a  

^a JOINT RESEARCH CENTRE   (Italy)

Author keywords

1,4 Naphthoquinone; 1 Naphthol; 2 Naphthol; CFU GM; Gender differences; Naphthalene

Indexed keywords

1 NAPHTHOL; 1,4 NAPHTHOQUINONE; 2 NAPHTHOL; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; MESSENGER RNA; NAPHTHALENE; NAPHTHOL DERIVATIVE;

ARTICLE; BLOOD CELL; BLOOD PLACENTA BARRIER; CELL PROLIFERATION; CLONOGENESIS; COLONY FORMING UNIT GM; ENZYME METABOLISM; FEMALE; GENE EXPRESSION; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MACROPHAGE; MALE; NEWBORN; PROTEIN EXPRESSION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TOXICOLOGY; UMBILICAL CORD;

CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP3A; FEMALE; FETAL BLOOD; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMATOPOIETIC STEM CELLS; HUMANS; INFANT, NEWBORN; MALE; NAPHTHALENES; NAPHTHOLS; NAPHTHOQUINONES; RNA, MESSENGER; SEX FACTORS;

ANIMALIA;

EID: 49149111854     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.06.004     Document Type: Article

References (67)

1. Abdo K.M., Grumbein S., Chou B.J., and Herbert R. Toxicity and carcinogenicity study in F344 rats following 2 years of whole-body exposure to naphthalene vapors. Inhalation Toxicology 13 (2001) 931-950
2. Abdo K.M., Eustis S.L., McDonald M., Jokinen M.P., Adkins Jr. B., and Haseman J.K. Naphthalene: a respiratory tract toxicant and carcinogen for mice. Inhalation Toxicology 4 (1992) 393
3. Anziulewicz J.A., Dick H.J., and Chiarulli E.E. Transplacental naphthalene poisoning. American Journal of Obstetrics and Gynecology 78 (1959) 519-521
4. Belles-Isles M., Ayotte P., Dewailly E., Weber J.P., and Roy R. Cord blood lymphocyte functions in newborns from a remote maritime population exposed to organochlorines and methylmercury. Journal of Toxicology and Environmental Health A 65 (2002) 165-182
5. Bieniek G., Cisowska G., Lusiak T., and Siwek A. Evaluation of exposure to benzene and naphthalene in coke plant workers. Medycyna Pracy 44 6 (1993) 579-586
6. Bock K.W., von Clausbruch U.S., and Winne D. Absorption and metabolism of Naphthalene and benzo(a)pyrene in the rat jejunum in situ. Medical Biology 57 (1979) 262-264
7. Bogen, K.T., Benson, J.M., Yost, G.S., Morris, J.B., Dahl, A.R., Clewell, H.J. III, Krishnan, K., Omiecinski, J.C., 2008. Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action. Regulatory Toxicology and Pharmacology: RTP, doi:10.1016/j.yrtph.2007.10.018
8. Bolton J.L., Trush M.A., Penning T.M., Dryhurst G., and Monks T.J. Role of quinones in toxicology. Chemical Research in Toxicology 13 (2000) 135-160
9. Buckpitt A.R., and Franklin R.B. Relationship of naphthalene and 2-methylnaphthalene metabolism to pulmonary bronchiolar epithelial cell necrosis. Pharmacology and Therapeutics 41 (1989) 393-410
10. Buckpitt A., Chang A., Weir A., Van Winkle L., Duan X., Philpot R., and Plopper C. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats and hamsters. Molecular Pharmacology 47 (1995) 74-81
11. Buckpitt A., Boland B., Isbell M., Morin D., Shultz M., Baldwin R., Chan K., Karlsson A., Lin C., Taff A., West J., Fanucchi M., VanWinkle L., and Plopper C. Naphthalene-induced respiratory tract toxicity: metabolic mechanisms of toxicity. Drug Metabolism Reviews 34 (2002) 791
12. Chichester C.H., Buckpitt A.R., Chang A., and Plopper C.G. Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells. Molecular Pharmacology 45 (1994) 664
13. Cho M., Jedrychowski R., Hammock B., and Buckpitt A. Fundamental and Applied Toxicology 22 (1994) 26
14. Cho T.M., Rose R.L., and Hodgson E. In vitro metabolism of naphthalene by human liver microsomal cytochrome P450 enzymes. Drug Metabolism and Disposition 34 (2006) 176-183
15. Deutsche Forschungsgemeinschaft (DFG), 2001. Commission for the investigation of health hazards of chemical compounds in the work area (2001) MAK and BAT values 2001. Report No. 37. Wiley-VCH, Weinheim.
16. Ding X., and Kaminsky L.S. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annual Review of Pharmacology and Toxicology 43 (2003) 149-173
17. Diodovich C., Malerba I., Bowe G., Acquati F., Bianchi M.G., Taramelli R., Parent-Massin D., and Gribaldo L. Naphthalene exposure: effects on gene expression and proliferation in human cord blood cells. Journal of Biochemical and Molecular Toxicology 17 (2003) 286-294
18. Eisele G.R. Naphthalene distribution in tissues of laying pullets, swine, and dairy cattle. Bulletin of Environmental Contamination and Toxicology 34 (1985) 549-556
19. Environmental Protection Agency (US EPA), 1986. Health and Environmental Effects Profile for Naphthalene. Prepared by the Environmental Criteria and Assessment Office, Office of Health and Environmental Assessment, US Environmental Protection Agency, Cincinnati, OH. EPA-CIN-P192.
20. Environmental Protection Agency (US EPA), 2003. .
21. Environmental Protection Agency (EPA), 2004. Toxicological Review of Naphthalene (CAS No. 91-20-3) in Support of Summary Information on the Integrated Risk Information System (IRIS). NCEA-S-1707, June 2004, External review draft. US EPA O.ce of Research and Development, Washington, DC.
22. Gelboin H.V. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiological Reviews 60 (1980) 1107-1166
23. Gosselin, R.E., et al., 1984. Clinical toxicology of commercial products. 5th ed. Williams and Wilkins, p. III-309.
24. Gribaldo L., Catalani P., and Marafante E. Metabolism of doxorubicin in long-term bone marrow cultures and SR-4987 stromal established cell line. Drug Metabolism and Drug Interactions 15 (1999) 279-291
25. Gribaldo L., Casati S., Castoldi A.F., and Pessina A. Comparison of in vitro drug-sensitivity of human granulocyte-macrophage progenitors from two different origins: umbilical cord blood and bone marrow. Experimental Hematology 27 (1999) 1593-1598
26. Hayes W.J. Pesticides Studies in Man (1982), Williams and Wilkins, Baltimore pp. 136-137
27. HEI Air Toxics Review Panel, 2007. Mobile-Source Air Toxics: A Critical Review of the Literature on Exposure and Health Effects. HEI Special Report 16. Health Effects Institute, Boston, MA.
28. Horning M.G., Stillwell W.G., Griffin G.W., and Tsang W.S. Epoxide intermediates in the metabolism of naphthalene by the rat. Drug Metabolism and Disposition 8 (1980) 404-414
29. International Agency for Research on Cancer (IARC), 2002. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. In: Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 82. IARC, France.
30. Lakritz J., Chang A., Weir A., Nishio S., Hyde D., Philpot R., Buckpitt A., and Plopper C. Cellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene. The Journal of Pharmacology and Experimental Therapeutics 278 (1996) 1408
31. Long P.H., Herbert R.A., Peckham J.C., Grumbein S.L., Shackelford C.C., and Abdo K.M. Morphology of nasal lesions in F344/N rats following chronic inhalation exposure to naphthalene vapors. Toxicologic Pathology 31 (2003) 655-664
32. Mc Dougal M.J.N., Pollard D.L., Weisman W., Garrett C.M., and Miller T.E. Assessment of skin absorption and penetration of JP-8 jet fuel and its components. Toxicological Sciences 55 (2000) 247-355
33. National Toxicology Programme (NTP), 1992. Natl. Toxicol. Program Tech. Rep. Ser. 410, 1.
34. National Toxicology Programme (NTP), 2000. NIH Publication No. 01-4434, USDHHS, NIH, Rockville, MD.
35. Naughton B.A., Sibanda B., Azar L., and San Roman J. Differential effects of drugs upon hematopoiesis can be assessed in long-term bone marrow cultures established on nylon screens. Proceedings of the Society for Experimental Biology and Medicine 199 (1992) 481-490
36. North, D.W., Abdo, K.M., Benson, J.M., Dahl, A.R., Morris, J.B., Renne, R., Witschi, H., 2007. A review of whole animal bioassays of the carcinogenic potential of naphthalene. Reg. Tox. Pharm., this issue, doi:10.1016/j/yrtph.2007.09.022.
37. O'Brien K.A., Smith L.L., and Cohen G.M. Differences in naphthalene-induced toxicity in the mouse and rat. Chemico-Biological Interactions 55 (1985) 109-122
38. O'Brien K.A., Suverkropp C., Kanekal S., Plopper C.G., and Buckpitt A.R. Tolerance to multiple doses of the pulmonary toxicant, naphthalene. Toxicology and Applied Pharmacology 99 (1989) 487-500
39. Parchment R. Alternative testing systems for evaluating noncarcinogenic, hemaologic toxicity. Environmental Health Perspectives 106 (1998) 541-557
40. Parent-Massin D. Relevance of clonogenic assay s in hemato-toxicology. Cell Biology and Toxicology 17 (2001) 87-94
41. Pellizzari E.D., Hartwell T.D., Harris III B.S., Waddell R.D., Whitaker D.A., and Erickson M.D. Purgeable organic compounds in mother's milk. Bulletin of Environmental Contamination and Toxicology 28 (1982) 322-328
42. Penning T.M. Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism. Chemico-Biological Interactions 89 (1993) 1-34
43. Pessina A., Albella B., Bueren J., Brantom P., Casati S., Gribaldo L., Croera C., Gagliardi G., Foti P., Parchment R., Parent-Massin D., Sibiril Y., and Van Den Heuvel R. Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicology In Vitro 15 (2001) 729-740
44. Plopper C.G., Suverkropp C., Morin D., Nishio S., and Buckpitt A. Relationship of cytochrome P450 activity to Clara cell cytotoxicity I. Histopathologic comparison of the respiratory tract in mice, rats and hamsters after parenteral administration of naphthalene. The Journal of Pharmacology and Experimental Therapeutics 261 (1992) 353-363
45. Preuss R., Angerer J., and Drexler H. Naphthalene-an environmental and occupational toxicant. International Archives of Occupational and Environmental Health 76 (2003) 556-576
46. Raunio H., Hakkola J., Hukkanen J., Lassila A., Paivarinta K., Pelkonen O., Anttila S., Piipari R., Boobis A., and Edwards R.J. Expression of xenobiotic-metabolizing CYPs in human pulmonary tissue. Experimental and Toxicologic Pathology 51 (1999) 412-417
47. Reed L.J., and Muench H. A simple method of estimating fifty per cent endpoints. American Journal of Hygiene 27 (1938) 493
48. Rio B., Lautraite S., and Parent-Massin D. In vitro toxicity of trichothecenes on human erythroblastic progenitors. Human and Experimental Toxicology 16 (1997) 673-679
49. Rio B., Parent-Massin D., Lautraite S., and Hoellinger H. Effects of a diphenyl-ether herbicide, oxyfluorfen, on human BFU-E/CFU-E development and haemoglobin synthesis. Human and Experimental Toxicology 16 (1997) 115-122
50. Ross D., Siegel D., Schattenberg D.G., Sun X.M., and Moran J.L. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity. Environmental Health Perspectives 104 Suppl. 6 (1996) 1177-1182
51. Schamhal D. Prüfung von Naphthalin und Anthracen auf cancerogene Wirkung an Ratten [A test of cancerogenic effects of naphthalene and anthracene in rats]. Zeitschrift Fur Krebsforschung 60 (1955) 697-710
52. Stanley, J., 1986. Broadscan Analysis of the FY 82 National Human Adipose Tissue Survey Specimens: Vol. 1-Executive Summary. Washington, DC, US Environmental Protection Agency, Office of Toxic Substances.
53. Stelck R.L., Baker G.L., Sutherland K.M., and Van Winkle L.S. Estrous cycle alters naphthalene metabolism in female mouse airways. Drug metabolism and disposition: the biological fate of chemicals 33 (2005) 1597-1602
54. Sumida A., Fukuen S., Yamamoto I., Matsuda H., Naohara M., and Azuma J. Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR. Biochemical and Biophysical Research Communications 267 (2000) 756-760
55. Tong S.S., Hirokata Y., Trush M.A., Mimnaugh E.G., Ginsburg E., Lowe M.C., and Gram T.E. Clara cell damage and inhibition of pulmonary mixed-function oxidase activity by naphthalene. Biochemical and Biophysical Research Communications 100 3 (1981) 944-950
56. Troester M.A., Lindstrom A.B., Waidyanatha S., Kupper L.L., and Rappaport S.M. Toxicological Sciences 68 (2002) 314
57. Turkall R.M., Skowronski G.A., Kadry M.A., and Abdel-Rahman M.S. A comparative study of the kinetics and bioavailability of pure and soil-absorbed naphthalene in dermally exposed male rats. Archives of Environmental Contamination and Toxicology 26 (1994) 504-509
58. Van Winkle L.S., Gunderson A.D., Shimizu J.D., Baker G.L., and Brown C.D. Gender differences in naphthalene metabolism and naphthalene-induced acute lung injury. American Journal of Physiology. Lung Cellular and Molecular Physiology 282 (2002) L1122-L1134
59. Waidyanatha S., Troester M.A., Lindstrom A.B., and Rappaport S.M. Measurement of hemoglobin and albumin adducts of naphthalene-1,2-oxide,1,2-naphthoquinone and 1,4-naphthoquinone after administration of naphthalene to F344 rats. Chemico-Biological Interactions 141 (2002) 189-210
60. Waidyanatha, S., Zheng, Y., Serdar, B., Rappaport, S.M., 2004. Cancer Epidemiology, Biomarkers & Prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 13, 117.
61. Waidyanatha S., and Rappaport S.M. Hemoglobin and albumin adducts of naphthalene-1,2-oxide, 1,2-naphthoquinone and 1,4-naphthoquinone in Swiss Webster mice. Chemico-Biological Interactions 172 (2008) 105-114
62. Weintraub E., Gandhi D., and Robinson C. Medical complications due to mothball abuse. The Southern Medical Journal 93 (2000) 427-429
63. Wells P.G., Wilson B., and Lubek B.M. In vivo murine studies on the biochemical mechanism of naphthalene cataractogenesis. Toxicology and Applied Pharmacology 99 (1989) 466-473
64. Wu R., Waidyanatha S., Henderson A.P., Serdar B., Zheng Y., and Rappaport S.M. Determination of dihydroxynaphthalenes in human urine by gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 826 (2005) 206-213
65. Xu G.T., Zigler Jr. J.S., and Lou M.F. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576). Experimental Eye Research 54 (1992) 63-72
66. Zheng J., Cho M., Jones A.D., and Hammock B.D. Evidence of quinone metabolites of naphthalene covalently bound to sulfur nucleophiles of proteins of murine Clara cells after exposure to naphthalene. Chemical Research in Toxicology 10 (1997) 1008
67. Zinkham W.H., and Childs B. A defect of glutathione metabolism in erythrocytes from patients with a naphthalene-induced hemolytic anemia. Pediatrics 22 (1958) 461-471